Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q962504> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Q962504 subject Q5920511.
- Q962504 subject Q7139608.
- Q962504 subject Q8297699.
- Q962504 subject Q8341873.
- Q962504 subject Q8503574.
- Q962504 subject Q8661590.
- Q962504 abstract "Dexanabinol (HU-211 or ETS2101) is a synthetic cannabinoid derivative in development by e-Therapeutics plc. It is the "unnatural" enantiomer of the potent cannabinoid agonist HU-210. Unlike other cannabinoid derivatives, HU-211 does not act as a cannabinoid receptor agonist, but instead has NMDA antagonist effects. It therefore does not produce cannabis-like effects, but is anticonvulsant and neuroprotective, and is widely used in scientific research as well as currently being studied for applications such as treating head injury, stroke, or cancer. It was shown to be safe in clinical trials and is currently undergoing Phase I trials for the treatment of brain cancer and advanced solid tumors.".
- Q962504 atcPrefix "none".
- Q962504 casNumber "112924-45-5".
- Q962504 fdaUniiCode "R6VT8U5372".
- Q962504 iupacName "(6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol".
- Q962504 pubchem "107778".
- Q962504 thumbnail HU-211_structure.png?width=300.
- Q962504 wikiPageWikiLink Q1981368.
- Q962504 wikiPageWikiLink Q233309.
- Q962504 wikiPageWikiLink Q30.
- Q962504 wikiPageWikiLink Q30612.
- Q962504 wikiPageWikiLink Q4044974.
- Q962504 wikiPageWikiLink Q411905.
- Q962504 wikiPageWikiLink Q421237.
- Q962504 wikiPageWikiLink Q422936.
- Q962504 wikiPageWikiLink Q494483.
- Q962504 wikiPageWikiLink Q5165931.
- Q962504 wikiPageWikiLink Q576618.
- Q962504 wikiPageWikiLink Q5920511.
- Q962504 wikiPageWikiLink Q7139608.
- Q962504 wikiPageWikiLink Q7180990.
- Q962504 wikiPageWikiLink Q812.
- Q962504 wikiPageWikiLink Q8297699.
- Q962504 wikiPageWikiLink Q8341873.
- Q962504 wikiPageWikiLink Q8503574.
- Q962504 wikiPageWikiLink Q8661590.
- Q962504 atcPrefix "none".
- Q962504 casNumber "112924".
- Q962504 iupacName "-9".
- Q962504 pubchem "107778".
- Q962504 unii "R6VT8U5372".
- Q962504 type ChemicalSubstance.
- Q962504 type Drug.
- Q962504 type ChemicalObject.
- Q962504 type Thing.
- Q962504 type Q8386.
- Q962504 comment "Dexanabinol (HU-211 or ETS2101) is a synthetic cannabinoid derivative in development by e-Therapeutics plc. It is the "unnatural" enantiomer of the potent cannabinoid agonist HU-210. Unlike other cannabinoid derivatives, HU-211 does not act as a cannabinoid receptor agonist, but instead has NMDA antagonist effects.".
- Q962504 label "Dexanabinol".
- Q962504 depiction HU-211_structure.png.